Formed by the merger of Gyros AB (founded in 2000) and Protein Technologies, Inc. (founded in 1985), Gyros Protein Technologies AB is a leading provider of solutions for peptide synthesis and bioanalysis. Our focus is on helping scientists in academia and industry increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. Proprietary, high-performance microfluidics immunoassay platforms, Gyrolab® xPand, Gyrolab® xP workstation and GyrolabxPlore™, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies for bioanalytical applications such as pharmacokinetics/pharmacodynamics, toxicokinetics, immunogenicity (ADA), product titer and quantitating bioprocess-related impurities. Gyrolab platforms automatically process samples in parallel at nanoliter-scale, allowing scientists to generate more information from less sample, improving productivity and efficiency. Our peptide synthesis and bioanalytical solutions accelerate your discovery, development, and manufacturing of safer biotherapeutics.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.